MicroSectors Gold Miners 3X Leveraged ETN

Direxion Daily S&P Biotech Bull 3X ETF

ProShares UltraShort Bloomberg Natrl Gas

Direxion Daily Gold Miners Bull 3X ETF

T-REX 2X Inverse Tesla Daily Target ETF

Direxion Daily 20+ Yr Trsy Bull 3X ETF

ProShares Ultra Silver

NEOS ETF Trust Kurv Yield Premium Strategy Netflix (NFLX) ETF

VanEck Vectors Junior Gold Miners ETF

Direxion Daily Financial Bull 3X ETF

GraniteShares 1.5x Long Coinbase Daily ETF

Mast Therapeutics, Inc.

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

Direxion Daily S&P Biotech Bear 3X ETF

GraniteShares 1.5x Long META Daily ETF

Volatility Shares Trust 2x Ether ETF

Direxion Daily Gold Miners Bear 3X ETF

ProShares Ultra Bloomberg Natural Gas

GraniteShares 2x Long AMZN Daily ETF

Direxion Daily FTSE China Bull 3X ETF

Click Holdings Limited Ordinary Share

Aytu BioPharma Inc.  Common Stock

Foot Locker Inc.

Kindly MD Inc. Common Stock

Gryphon Digital Mining Inc Common Stock

LOBO EV TECHNOLOGIES LTD. Ordinary shares

Next Technology Holding Inc. Ordinary Shares

Siyata Mobile Inc. Common Shares

SolarEdge Technologies Inc. Common Stock

Asset Entities Inc. Class B Common Stock

Incannex Healthcare Limited American Depositary Shares

Crown LNG Holdings Limited Ordinary Shares

Luminar Technologies Inc.  Class A Common Stock

MicroAlgo Inc. Ordinary Shares

Dick's Sporting Goods Inc Common Stock

Plug Power Inc. Common Stock

Freight Technologies Inc. Ordinary Shares

HWH International Inc. Common Stock

ScanTech AI Systems Inc. Common stock

Twin Vee PowerCats Co. Common Stock

Click here to get full coverage on Comprehensive bioinformatics analysis of MEX3 family genes in hepatocellular carcinoma - Nature

Comprehensive bioinformatics analysis of MEX3 family genes in hepatocellular carcinoma  Nature

Comprehensive bioinformatics analysis of MEX3 family genes in hepatocellular carcinoma - Nature

Click here to get full coverage on HCC Spring 2025 Graduation Issue - hccegalitarian.com

HCC Spring 2025 Graduation Issue  hccegalitarian.com

HCC Spring 2025 Graduation Issue - hccegalitarian.com

Click here to get full coverage on The Application for the HCC Back2School Backpack Program is Now Open - 94.5 The Buzz

The Application for the HCC Back2School Backpack Program is Now Open  94.5 The Buzz

The Application for the HCC Back2School Backpack Program is Now Open - 94.5 The Buzz

Click here to get full coverage on HCC invites students to register for summer, fall classes at Pathfinder Days - whopam.com

HCC invites students to register for summer, fall classes at Pathfinder Days  whopam.com

HCC invites students to register for summer, fall classes at Pathfinder Days - whopam.com

Click here to get full coverage on Holyoke Community College to celebrate scholarship recipients with May 15 reception - MassLive

Holyoke Community College to celebrate scholarship recipients with May 15 reception  MassLive

Holyoke Community College to celebrate scholarship recipients with May 15 reception - MassLive

Click here to get full coverage on New cybersecurity program at Harford Community College aims to help students find jobs - Baltimore Sun

New cybersecurity program at Harford Community College aims to help students find jobs  Baltimore Sun

New cybersecurity program at Harford Community College aims to help students find jobs - Baltimore Sun

Click here to get full coverage on SCG101 Shows Antiviral and Antitumor Activity in Advanced HBV-Related HCC - OncLive

SCG101 Shows Antiviral and Antitumor Activity in Advanced HBV-Related HCC  OncLive

SCG101 Shows Antiviral and Antitumor Activity in Advanced HBV-Related HCC - OncLive

Click here to get full coverage on FDA Approves Nivolumab/Ipilimumab for Metastatic or Unresectable HCC - Oncology Nursing News

FDA Approves Nivolumab/Ipilimumab for Metastatic or Unresectable HCC  Oncology Nursing News

FDA Approves Nivolumab/Ipilimumab for Metastatic or Unresectable HCC - Oncology Nursing News

Click here to get full coverage on New Developments Warrant Rethinking HCC Transplant Criteria - AJMC

New Developments Warrant Rethinking HCC Transplant Criteria  AJMC

New Developments Warrant Rethinking HCC Transplant Criteria - AJMC

Click here to get full coverage on Hydropower Collegiate Competition (HCC) - Purdue Polytechnic Institute

Hydropower Collegiate Competition (HCC)  Purdue Polytechnic Institute

Hydropower Collegiate Competition (HCC) - Purdue Polytechnic Institute

Click here to get full coverage on TACE Plus Drug Combination Effective in Liver Cancer - National Cancer Institute (.gov)

TACE Plus Drug Combination Effective in Liver Cancer  National Cancer Institute (.gov)

TACE Plus Drug Combination Effective in Liver Cancer - National Cancer Institute (.gov)

Click here to get full coverage on Multi-omic analysis reveals a CAF-stemness-governed classification in HCC liver transplant recipients beyond the Milan criteria - Nature

Multi-omic analysis reveals a CAF-stemness-governed classification in HCC liver transplant recipients beyond the Milan criteria  Nature

Multi-omic analysis reveals a CAF-stemness-governed classification in HCC liver transplant recipients beyond the Milan criteria - Nature

Click here to get full coverage on Botensilimab Plus Balstilimab Elicits Durable Responses in Treatment-Refractory HCC - OncLive

Botensilimab Plus Balstilimab Elicits Durable Responses in Treatment-Refractory HCC  OncLive

Botensilimab Plus Balstilimab Elicits Durable Responses in Treatment-Refractory HCC - OncLive

Click here to get full coverage on Dimethyl fumarate abrogates hepatocellular carcinoma growth by inhibiting Nrf2/Bcl-xL axis and enhances sorafenib’s efficacy - Nature

Dimethyl fumarate abrogates hepatocellular carcinoma growth by inhibiting Nrf2/Bcl-xL axis and enhances sorafenib’s efficacy  Nature

Dimethyl fumarate abrogates hepatocellular carcinoma growth by inhibiting Nrf2/Bcl-xL axis and enhances sorafenib’s efficacy - Nature

Click here to get full coverage on Nivolumab Plus Ipilimumab Receives EC Approval for First-Line Unresectable HCC - OncLive

Nivolumab Plus Ipilimumab Receives EC Approval for First-Line Unresectable HCC  OncLive

Nivolumab Plus Ipilimumab Receives EC Approval for First-Line Unresectable HCC - OncLive

Click here to get full coverage on Multicenter, prospective clinical trial for balloon-occluded alternative infusion of cisplatin solution and fragmented gelatin particles of transarterial chemoembolization for hepatocellular carcinoma beyond up-to-seven criteria - Nature

Multicenter, prospective clinical trial for balloon-occluded alternative infusion of cisplatin solution and fragmented gelatin particles of transarterial chemoembolization for hepatocellular carcinoma beyond up-to-seven criteria  Nature

Multicenter, prospective clinical trial for balloon-occluded alternative infusion of cisplatin solution and fragmented gelatin particles of transarterial chemoembolization for hepatocellular carcinoma beyond up-to-seven criteria - Nature

Click here to get full coverage on Tislelizumab Pushes HCC Field Forward With 2024 NCCN Guideline Category 1 Recommendation - OncLive

Tislelizumab Pushes HCC Field Forward With 2024 NCCN Guideline Category 1 Recommendation  OncLive

Tislelizumab Pushes HCC Field Forward With 2024 NCCN Guideline Category 1 Recommendation - OncLive

Click here to get full coverage on Nivolumab/Ipilimumab Approaches EU Approval in Unresectable or Advanced HCC - OncLive

Nivolumab/Ipilimumab Approaches EU Approval in Unresectable or Advanced HCC  OncLive

Nivolumab/Ipilimumab Approaches EU Approval in Unresectable or Advanced HCC - OncLive

Click here to get full coverage on Hepatocellular carcinoma: signaling pathways and therapeutic advances | Signal Transduction and Targeted Therapy - Nature

Hepatocellular carcinoma: signaling pathways and therapeutic advances | Signal Transduction and Targeted Therapy  Nature

Hepatocellular carcinoma: signaling pathways and therapeutic advances | Signal Transduction and Targeted Therapy - Nature

Click here to get full coverage on RZ-001 Earns FDA Fast Track Designation in HCC - OncLive

RZ-001 Earns FDA Fast Track Designation in HCC  OncLive

RZ-001 Earns FDA Fast Track Designation in HCC - OncLive

Click here to get full coverage on Tokio Marine HCC International Appoints Thibaud Hervy as CEO with Simon Button Promoted to International CUO - GlobeNewswire

Tokio Marine HCC International Appoints Thibaud Hervy as CEO with Simon Button Promoted to International CUO  GlobeNewswire

Tokio Marine HCC International Appoints Thibaud Hervy as CEO with Simon Button Promoted to International CUO - GlobeNewswire

Click here to get full coverage on HCC cancels student trip to London, citing fears of Trump immigration crackdown - Houston Landing

HCC cancels student trip to London, citing fears of Trump immigration crackdown  Houston Landing

HCC cancels student trip to London, citing fears of Trump immigration crackdown - Houston Landing

Click here to get full coverage on Amezalpat Gains FDA Orphan Drug Status in HCC - Targeted Oncology

Amezalpat Gains FDA Orphan Drug Status in HCC  Targeted Oncology

Amezalpat Gains FDA Orphan Drug Status in HCC - Targeted Oncology

Click here to get full coverage on Nivolumab/Ipilimumab Establishes Unprecedented Efficacy and Safety Standards in Advanced HCC - OncLive

Nivolumab/Ipilimumab Establishes Unprecedented Efficacy and Safety Standards in Advanced HCC  OncLive

Nivolumab/Ipilimumab Establishes Unprecedented Efficacy and Safety Standards in Advanced HCC - OncLive

Click here to get full coverage on Interest in HCC’s most popular degree is plummeting — and that’s by design - Houston Landing

Interest in HCC’s most popular degree is plummeting — and that’s by design  Houston Landing

Interest in HCC’s most popular degree is plummeting — and that’s by design - Houston Landing

Click here to get full coverage on Noninvasive prognostic classification of ITH in HCC with multi-omics insights and therapeutic implications - Science | AAAS

Noninvasive prognostic classification of ITH in HCC with multi-omics insights and therapeutic implications  Science | AAAS

Noninvasive prognostic classification of ITH in HCC with multi-omics insights and therapeutic implications - Science | AAAS

Click here to get full coverage on HCC asked 1,800 people about changing the community college’s name. Here’s what they said. - Houston Landing

HCC asked 1,800 people about changing the community college’s name. Here’s what they said.  Houston Landing

HCC asked 1,800 people about changing the community college’s name. Here’s what they said. - Houston Landing

Click here to get full coverage on Houston Community College enrollment soars in the suburbs, shrinks in the city - Houston Landing

Houston Community College enrollment soars in the suburbs, shrinks in the city  Houston Landing

Houston Community College enrollment soars in the suburbs, shrinks in the city - Houston Landing

Click here to get full coverage on Help wanted: Many HCC international students scramble for work, but few get it - Houston Landing

Help wanted: Many HCC international students scramble for work, but few get it  Houston Landing

Help wanted: Many HCC international students scramble for work, but few get it - Houston Landing

Click here to get full coverage on Validation study examines accuracy of the GALAD score algorithm for diagnosing HCC in sub-Saharan Africans - Mayo Clinic

Validation study examines accuracy of the GALAD score algorithm for diagnosing HCC in sub-Saharan Africans  Mayo Clinic

Validation study examines accuracy of the GALAD score algorithm for diagnosing HCC in sub-Saharan Africans - Mayo Clinic

Click here to get full coverage on Fritos for lunch, Skittles for dinner: Many HCC students can’t get fresh meals on campus - Houston Landing

Fritos for lunch, Skittles for dinner: Many HCC students can’t get fresh meals on campus  Houston Landing

Fritos for lunch, Skittles for dinner: Many HCC students can’t get fresh meals on campus - Houston Landing

Click here to get full coverage on SAR444200 Demonstrates Safety, Signals of Clinical Activity in Advanced GPC3+ HCC, Other Solid Tumors - OncLive

SAR444200 Demonstrates Safety, Signals of Clinical Activity in Advanced GPC3+ HCC, Other Solid Tumors  OncLive

SAR444200 Demonstrates Safety, Signals of Clinical Activity in Advanced GPC3+ HCC, Other Solid Tumors - OncLive

Click here to get full coverage on Neoadjuvant immune checkpoint inhibitors for hepatocellular carcinoma - Nature

Neoadjuvant immune checkpoint inhibitors for hepatocellular carcinoma  Nature

Neoadjuvant immune checkpoint inhibitors for hepatocellular carcinoma - Nature

Click here to get full coverage on HCC board votes to settle anti-discrimination suits in tense meeting - Houston Chronicle

HCC board votes to settle anti-discrimination suits in tense meeting  Houston Chronicle

HCC board votes to settle anti-discrimination suits in tense meeting - Houston Chronicle

Click here to get full coverage on Green jackfruit flour ameliorates MASH and development of HCC via the AMPK and MAPK signaling pathways in experimental model systems - Nature

Green jackfruit flour ameliorates MASH and development of HCC via the AMPK and MAPK signaling pathways in experimental model systems  Nature

Green jackfruit flour ameliorates MASH and development of HCC via the AMPK and MAPK signaling pathways in experimental model systems - Nature

Click here to get full coverage on The epigenetic basis of hepatocellular carcinoma – mechanisms and potential directions for biomarkers and therapeutics | British Journal of Cancer - Nature

The epigenetic basis of hepatocellular carcinoma – mechanisms and potential directions for biomarkers and therapeutics | British Journal of Cancer  Nature

The epigenetic basis of hepatocellular carcinoma – mechanisms and potential directions for biomarkers and therapeutics | British Journal of Cancer - Nature

Click here to get full coverage on FDA Grants Orphan Drug Designation to Amezalpat for Advanced HCC - OncLive

FDA Grants Orphan Drug Designation to Amezalpat for Advanced HCC  OncLive

FDA Grants Orphan Drug Designation to Amezalpat for Advanced HCC - OncLive

Click here to get full coverage on HCC had big plans for a $30M natural disaster training facility. Why wasn’t it built? - Houston Landing

HCC had big plans for a $30M natural disaster training facility. Why wasn’t it built?  Houston Landing

HCC had big plans for a $30M natural disaster training facility. Why wasn’t it built? - Houston Landing

Click here to get full coverage on Development of a MVI associated HCC prognostic model through single cell transcriptomic analysis and 101 machine learning algorithms - Nature

Development of a MVI associated HCC prognostic model through single cell transcriptomic analysis and 101 machine learning algorithms  Nature

Development of a MVI associated HCC prognostic model through single cell transcriptomic analysis and 101 machine learning algorithms - Nature

Click here to get full coverage on Tokio Marine HCC President to step down - Insurance Business America

Tokio Marine HCC President to step down  Insurance Business America

Tokio Marine HCC President to step down - Insurance Business America

Click here to get full coverage on NMPA Approves sNDA for Toripalimab Plus Bevacizumab in Advanced HCC - OncLive

NMPA Approves sNDA for Toripalimab Plus Bevacizumab in Advanced HCC  OncLive

NMPA Approves sNDA for Toripalimab Plus Bevacizumab in Advanced HCC - OncLive

Click here to get full coverage on Invariant NK T cells counteract HCC metastasis by mediating the migration of splenic CD4 - Nature

Invariant NK T cells counteract HCC metastasis by mediating the migration of splenic CD4  Nature

Invariant NK T cells counteract HCC metastasis by mediating the migration of splenic CD4 - Nature

Click here to get full coverage on Oncolytic virus VG161 in refractory hepatocellular carcinoma - Nature

Oncolytic virus VG161 in refractory hepatocellular carcinoma  Nature

Oncolytic virus VG161 in refractory hepatocellular carcinoma - Nature

Click here to get full coverage on Several Tokio Marine HCC Companies File Collective Notice of Data Breach - JD Supra

Several Tokio Marine HCC Companies File Collective Notice of Data Breach  JD Supra

Several Tokio Marine HCC Companies File Collective Notice of Data Breach - JD Supra

Click here to get full coverage on Surgical Resection of a Retrocaval Hepatocellular Carcinoma: Defining Tumor-Vein Interface in Oncologic High-Risk Tumors - American College of Surgeons

Surgical Resection of a Retrocaval Hepatocellular Carcinoma: Defining Tumor-Vein Interface in Oncologic High-Risk Tumors  American College of Surgeons

Surgical Resection of a Retrocaval Hepatocellular Carcinoma: Defining Tumor-Vein Interface in Oncologic High-Risk Tumors - American College of Surgeons

Click here to get full coverage on FDA Fast Tracks Amezalpat for HCC Treatment - Targeted Oncology

FDA Fast Tracks Amezalpat for HCC Treatment  Targeted Oncology

FDA Fast Tracks Amezalpat for HCC Treatment - Targeted Oncology

Click here to get full coverage on FDA Accepts Nivolumab/Ipilimumab Application for First-Line HCC Treatment - Targeted Oncology

FDA Accepts Nivolumab/Ipilimumab Application for First-Line HCC Treatment  Targeted Oncology

FDA Accepts Nivolumab/Ipilimumab Application for First-Line HCC Treatment - Targeted Oncology

Click here to get full coverage on TACE and Durvalumab/Bevacizumab in Unresectable HCC - The ASCO Post

TACE and Durvalumab/Bevacizumab in Unresectable HCC  The ASCO Post

TACE and Durvalumab/Bevacizumab in Unresectable HCC - The ASCO Post

Click here to get full coverage on Tokio Marine HCC President Mike Schell Retires After Five Decades in Insurance - GlobeNewswire

Tokio Marine HCC President Mike Schell Retires After Five Decades in Insurance  GlobeNewswire

Tokio Marine HCC President Mike Schell Retires After Five Decades in Insurance - GlobeNewswire

Click here to get full coverage on Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications - Nature

Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications  Nature

Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications - Nature

Click here to get full coverage on Houston Community College leaders pump the brakes on a potential name change - Houston Landing

Houston Community College leaders pump the brakes on a potential name change  Houston Landing

Houston Community College leaders pump the brakes on a potential name change - Houston Landing

Click here to get full coverage on Knights swept by No. 1-ranked HCC in Florida matinee - Carleton College

Knights swept by No. 1-ranked HCC in Florida matinee  Carleton College

Knights swept by No. 1-ranked HCC in Florida matinee - Carleton College

Click here to get full coverage on Here’s where Houston Community College students, staff can find food assistance on campus - Houston Landing

Here’s where Houston Community College students, staff can find food assistance on campus  Houston Landing

Here’s where Houston Community College students, staff can find food assistance on campus - Houston Landing

Click here to get full coverage on Houston Community College is taking students ‘into the metaverse.’ Here’s what that means. - Houston Landing

Houston Community College is taking students ‘into the metaverse.’ Here’s what that means.  Houston Landing

Warrior Met Coal Inc (HCC)

Price Chart

Key Statistics

Technicals

About HCC

Latest News

Comprehensive bioinformatics analysis of MEX3 family genes in hepatocellular carcinoma - Nature

HCC Spring 2025 Graduation Issue - hccegalitarian.com

The Application for the HCC Back2School Backpack Program is Now Open - 94.5 The Buzz

Advanced Charts

Top Gainers

Top Losers